Bene Meat Technologies

Bene Meat Technologies a.s., also known as BeneMeat, is a Czech biotechnology start-up focused on the research, development, and industrial scaling of cultivated meat. Founded in Prague in 2020 by Roman Kříž, the company is organized primarily as a technology developer and partner rather than as a conventional consumer meat producer. Its stated objective is to create an integrated platform that can help manufacturers develop and commercialize cultivated-meat products through the combined provision of cell-line development, culture-media technology, bioprocess engineering, production scaling, and regulatory expertise. The company’s research centers on expanding animal cells without relying on fetal bovine serum. BeneMeat has described the development of growth factors produced through its own systems as an important part of its research direction, because the elimination of animal-derived serum is relevant to cost, consistency, scalability, and the ethical positioning of cultivated meat. The company has also presented affordability as a long-term goal, arguing that a commercially viable production system must reduce the cost of cultivated meat sufficiently for broad consumer access. Although BeneMeat has identified human food as a strategic objective, its earliest announced market pathway has been pet food. In 2023, the company said that its first market product might be intended for dogs and cats rather than people. BeneMeat subsequently became the first company recorded in the European Feed Materials Register for the production and sale of cultivated meat for pet-food use, according to the company and referenced descriptions of its work. This regulatory and market orientation distinguishes BeneMeat from cultivated-meat ventures focused exclusively on human restaurants or packaged foods. The company collaborates with scientific institutions and commercial organizations in the Czech Republic and abroad. Its Prague headquarters are located in the Cube office building in the Vokovice district. The scientific organization has expanded considerably: the research team was reported to include approximately 70 scientists in 2022 and more than 100 members by 2025. Roman Kříž serves as project leader, Jiří Janoušek is identified as the principal biologist of the scientific team, and immunologist Jan Černý has participated as an external scientific expert. BeneMeat has pursued both technical validation and commercial demonstration. Its activities have included pilot-scale production work, planned industrial capacity for pet-food ingredients, animal acceptance trials, sustainability assessment, and cooperation with downstream pet-food companies. In 2025, its Try & Share Program involved dog owners testing food containing cultivated meat; the company reported that approximately nine out of ten participating dogs accepted the product. A later collaboration with Ghent University examined cultivated-meat-based feed in cats and reported acceptance and digestibility results broadly comparable with a chicken-based control diet. The company’s visibility increased through awards and industry recognition. In 2024, it received the Industrie Award within the Česká hlava project for its cultivated-meat research and technology. In 2025, it was included in the FoodTech 500, a ranking covering innovative food and agri-tech companies. BeneMeat has also commissioned life-cycle work to assess the environmental performance of its production system. The company’s broader positioning is therefore that of an industrial biotechnology and food-technology platform: it aims to supply enabling technology and expertise across the cultivated-meat value chain while using pet food as an early route to commercialization and retaining human food as a longer-term ambition.

Bene Meat Technologies a.s. was established in Prague in 2020 by Roman Kříž, who became the project leader. From its beginning, the company concentrated on the enabling technologies required to produce cultivated meat at industrial scale rather than presenting itself primarily as a branded finished-food manufacturer. Its intended role was to connect biological research with manufacturing: developing animal-cell lines, formulating culture media, improving bioprocesses, supporting scale-up, and sharing regulatory knowledge with prospective producers. The company’s technical program has emphasized the propagation of animal cells without fetal bovine serum. BeneMeat has also described the development of growth factors from its own production as a desired direction. These goals address several barriers to cultivated-meat commercialization, including the price of media, batch consistency, animal-origin inputs, and the difficulty of transferring laboratory methods into large production systems. The company has stated that its eventual technology should support products affordable enough for ordinary consumers, although no verified commercial pricing has been established. BeneMeat’s scientific network includes Czech and international institutions and companies. Jiří Janoušek has been identified as the leading biologist of the scientific team, while immunologist Jan Černý has participated as an external scientist. The team was reported to number about 70 scientists in 2022 and to have grown beyond 100 members by 2025. This expansion reflects the multidisciplinary nature of the program, which involves cell biology, bioprocess engineering, food technology, regulatory affairs, and product testing. The company initially identified pet food as a more immediate application than human food. In March 2023, BeneMeat said that its first cultivated-meat product reaching the market might be unsuitable for human consumption but appropriate for dogs and cats. At the same time, it continued to describe human-edible meat as one of its long-term objectives. The pet-food route provided a practical setting for testing production, feed safety, animal acceptance, and commercial partnerships while the regulatory pathway for cultivated meat intended for people remained more complex. BeneMeat became the first company recorded in the European Feed Materials Register for the production and sale of cultivated meat for pet-food use, specifically for cat and dog food, according to accounts of the company’s progress. It announced an ambition to reach production volumes of several metric tons per day for this market. The company has therefore positioned regulatory registration and industrial process development as central milestones, rather than treating cultivated meat solely as a laboratory demonstration. In 2024, BeneMeat commissioned a life-cycle assessment of its production system to examine resource use and environmental performance. Subsequent descriptions of the work reported lower land use and lower greenhouse-gas emissions than conventional meat production under the assessed conditions. The reported analysis used pilot-operation data and models for a future industrial facility, and projected additional reductions if process and energy efficiencies were achieved. These findings form part of the company’s effort to substantiate sustainability claims, although the results depend on system boundaries, energy sources, scale, and future process assumptions. The company also began testing consumer and animal acceptance. Its 2025 Try & Share Program involved dog owners providing food containing cultivated meat to their pets, with BeneMeat reporting acceptance by roughly 90% of participating dogs. A later study conducted with Ghent University assessed cultivated-meat-based feed in cats. The reported results indicated that nine of ten tested cats accepted the diet, that leftovers were lower than in the chicken-based control group, and that nutrient digestion and physiological measures were broadly comparable between the diets. BeneMeat’s public profile grew through recognition from the Czech innovation community and the international food-technology sector. It received the Industrie Award in the 2024 Česká hlava project and appeared in the 2025 FoodTech 500 ranking. At the 2026 Interzoo trade fair, Italian pet-food brand FORZA10 presented Coolty Meat, reported to contain 26% BeneMeat cultivated meat. The product was described as a single-protein dog food without antibiotics, hormones, or preservatives and was aimed especially at dogs with allergies or intolerances. By this stage, Bene Meat Technologies had developed a distinctive business identity: it was not simply a cultivated-meat label, but a biotechnology partner seeking to provide the biological, engineering, regulatory, and production infrastructure needed by other manufacturers. Its early commercial emphasis remained pet food, while human food, lower-cost media, industrial capacity, and improved sustainability continued to define its longer-term research agenda.

1. 2026Cat-feed digestibility and acceptance study

   A Ghent University collaboration evaluated cultivated-meat-based feed in cats and reported acceptance and nutrient-use results comparable with a chicken-based control diet.
2. 2026FORZA10 launches Coolty Meat

   FORZA10 introduced a dog-food product reported to contain 26% cultivated meat produced by BeneMeat at Interzoo in Nuremberg.
3. 2025Research team exceeds 100 members

   BeneMeat’s team was reported to have grown to more than 100 members.

   Source
4. 2025FoodTech 500 inclusion

   The company was included in the FoodTech 500 ranking of innovative food and agri-tech companies.

   Source
5. 2025Try & Share Program

   BeneMeat conducted a dog-food trial involving cultivated meat and reported acceptance by approximately 90% of participating dogs.
6. 2024Industrie Award recognition

   BeneMeat received the Industrie Award within the Česká hlava project for its research and technology in cultivated meat.

   Source
7. 2024Life-cycle assessment commissioned

   The company commissioned an assessment of the environmental performance of its cultivated-meat production system.
8. 2023Pet food identified as an initial market pathway

   BeneMeat stated that its first market product might be cultivated meat for pet food, while retaining human food as a longer-term objective.

   Source
9. 2022Scientific team reaches approximately 70 members

   The company’s cultivated-meat research team was reported to include about 70 scientists.

   Source
10. 2020Company founded in Prague

    Roman Kříž founded Bene Meat Technologies as a Czech biotechnology start-up focused on cultivated-meat research and industrial technology.

    Source

A Czech cultivated-meat technology partner focused on industrial scalability, serum-free cell cultivation, regulatory enablement, and an initial pet-food route to market.

• Cultivated meat for pet foodPet-food ingredient

  BeneMeat’s first stated commercial application is cultivated meat for dog and cat food. The company has pursued production and regulatory readiness for feed use, with the aim of supplying an ingredient that can be incorporated into finished pet-food formulas. This pathway allows the company to develop industrial processes and test animal acceptance before broader commercialization of cultivated meat for human consumption.

• Cultivated-meat technology ecosystemBiotechnology platform

  The company’s principal offering is an integrated technology platform for cultivated-meat manufacturers. It spans cell-line development, serum-free culture media, growth-factor research, bioprocess optimization, scale-up, and regulatory knowledge. BeneMeat presents itself as a technology partner capable of supporting multiple stages between laboratory research and industrial production rather than as only a seller of finished consumer products.

• Coolty MeatComplete dog food2026

  Coolty Meat is a FORZA10 dog-food product reported to contain 26% cultivated meat produced by BeneMeat. It was presented as a single-protein formula without antibiotics, hormones, or preservatives, with positioning directed particularly toward dogs affected by food allergies or intolerances.

• 2025Try & Share Program

  Pet food · Czech Republic

  BeneMeat invited dog owners to participate in a trial of pet food containing cultivated meat. The program was intended to gather practical evidence about animal acceptance and the suitability of cultivated meat as a pet-food ingredient.

  Outcome. The company reported that approximately 90% of participating dogs accepted the product.

• 2026Support downstream launch of Coolty MeatProduct launch

  BeneMeat sought to demonstrate that cultivated meat could be incorporated into a finished commercial pet-food formula.

  What changed. FORZA10 introduced Coolty Meat, reported to contain 26% BeneMeat cultivated meat, at Interzoo in Nuremberg.

  Aftermath. The launch provided a downstream commercial example of BeneMeat’s technology in a single-protein dog-food product.
• 2025Launch the Try & Share ProgramProduct launch

  Animal acceptance is a practical requirement for cultivated-meat pet food and cannot be established solely through laboratory production tests.

  What changed. The company arranged a dog-owner trial of food containing cultivated meat.

  Aftermath. BeneMeat reported that approximately nine in ten participating dogs accepted the product.
• 2024Commission a life-cycle assessmentStrategy

  Cultivated-meat companies face scrutiny over energy use, emissions, land use, and the assumptions behind future industrial production.

  What changed. BeneMeat commissioned an assessment of the environmental performance of its cultivated-meat production system using pilot data and models for a future industrial facility.

  Aftermath. The reported analysis indicated lower land use and lower greenhouse-gas emissions than conventional meat under the assessed conditions, with further reductions projected after process optimization.
• 2023Prioritize pet food as an initial commercialization routeStrategy

  BeneMeat was developing cultivated meat for both human and animal consumption, but the regulatory and product-development pathway for pet food offered an earlier potential route to market.

  What changed. The company stated that its first cultivated-meat product might be intended for dogs and cats rather than humans, while continuing to describe human food as a long-term goal.

  Aftermath. BeneMeat pursued feed registration, pet acceptance trials, and downstream pet-food partnerships.

  Source

• 2026FORZA10 introduces Coolty Meat containing BeneMeat cultivated meat

  At Interzoo in Nuremberg, FORZA10 introduced Coolty Meat, a complete dog food reported to contain 26% cultivated meat produced by BeneMeat.

  Product launch
• 2025Bene Meat Technologies enters the FoodTech 500

  The company was included in the FoodTech 500 ranking of innovative food and agri-tech businesses.

  Other
  Source
• 2025BeneMeat reports results from its Try & Share dog-food program

  In a program involving dog owners, the company reported that approximately 90% of participating dogs accepted food containing cultivated meat.

  Product launchOther
• 2024Bene Meat Technologies receives Industrie Award

  The company received the Industrie Award within the Česká hlava project in recognition of its cultivated-meat research and technology.

  Other
  Source
• 2024Bene Meat Technologies advances cultivated meat for pet food

  BeneMeat pursued the development of several-ton-per-day production capacity for cultivated meat intended for pet-food applications.

  Product launch
  Source

1. Bene Meat Technologies